Follow
geeta karadkhele
Title
Cited by
Cited by
Year
CMV high-risk status and posttransplant outcomes in kidney transplant recipients treated with belatacept
G Karadkhele, J Hogan, W Magua, W Zhang, IR Badell, A Mehta, M Lyon, ...
American Journal of Transplantation 21 (1), 208-221, 2021
552021
Abatacept as rescue immunosuppression after calcineurin inhibitor treatment failure in renal transplantation
IR Badell, GM Karadkhele, P Vasanth, AB Farris III, JM Robertson, ...
American Journal of Transplantation 19 (8), 2342-2349, 2019
262019
CMV status drives distinct trajectories of CD4+ T cell differentiation
W Zhang, AB Morris, EV Peek, G Karadkhele, JM Robertson, HT Kissick, ...
Frontiers in immunology 12, 620386, 2021
182021
Sex and glomerular filtration rate trajectories in children
S Bonnéric, G Karadkhele, C Couchoud, RE Patzer, LA Greenbaum, ...
Clinical Journal of the American Society of Nephrology 15 (3), 320-329, 2020
152020
Every 2‐month belatacept maintenance therapy in kidney transplant recipients greater than 1‐year posttransplant: A randomized, noninferiority trial
IR Badell, RF Parsons, G Karadkhele, O Cristea, S Mead, S Thomas, ...
American Journal of Transplantation 21 (9), 3066-3076, 2021
132021
Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement
MH Woodworth, RE Conrad, M Haldopoulos, SM Pouch, A Babiker, ...
Science Translational Medicine 15 (720), eabo2750, 2023
112023
Temporal trends and current use of de novo belatacept in kidney transplant recipients in the United States
G Karadkhele, C Duneton, R Garro, IR Badell, TC Pearson, CP Larsen, ...
Clinical Transplantation 36 (3), e14531, 2022
92022
Belatacept conversion in kidney after liver transplantation
O Cristea, G Karadkhele, WH Kitchens, P Vasanth, CP Larsen, IR Badell
Transplantation Direct 7 (11), e780, 2021
62021
Impact of belatacept and tacrolimus on cytomegalovirus viral load control and relapse in moderate and high‐risk cytomegalovirus serostatus kidney transplant recipients
W Magua, AC Johnson, GM Karadkhele, IR Badell, P Vasanth, AK Mehta, ...
Transplant Infectious Disease 24 (6), 13983, 2022
32022
Three-year Outcomes after Conversion from Monthly to Every 2-month Belatacept Maintenance Therapy in Kidney Transplant Recipients: results from a randomized controlled trial
AC Johnson, GM Karadkhele, N Shenvi, KA Easley, CP Larsen, IR Badell
Transplantation Direct 9 (3), e1449, 2023
12023
Longitudinal Evaluation of Cytopenias in the Renal Transplant Population
AC Johnson, G Karadkhele, W Magua, P Vasanth, CP Larsen
Transplantation Direct 8 (6), e1339, 2022
12022
Leukopenia in the renal transplant population
A Johnson, G Karadkhele, C Larsen
AMERICAN JOURNAL OF TRANSPLANTATION 21, 574-574, 2021
12021
Risk factors and outcomes of bloodstream infection from a urinary source in kidney transplant recipients
EM Eichenberger, MW Donzo, R Anderson, G Karadkhele, SM Pouch, ...
Clinical Transplantation 38 (3), e15279, 2024
2024
The Burden and Impact of Early Post-Transplant Multidrug-resistant Organism Detection Among Renal Transplant Recipients, 2005-2021
A Babiker, G Karadkhele, A Bombin, R Watkins, C Robichaux, G Smith, ...
Open Forum Infectious Diseases, ofae060, 2024
2024
Impact of an ultrasensitive Cytomegalovirus quantitative nucleic acid test on Cytomegalovirus detection and therapy in renal transplant recipients
VB Beechar, SM Pouch, VK Phadke, G Karadkhele, CP Larsen, ...
Transplant Infectious Disease 26 (1), e14219, 2024
2024
Belatacept with time-limited tacrolimus coimmunosuppression modifies the 3-year risk of eplet mismatch in kidney transplantation
AC Johnson, J Zhang, G Karadkhele, L Gragert, V Hertzberg, CP Larsen
American Journal of Transplantation 24 (2), 260-270, 2024
2024
Post-transplant lymphoproliferative disorder risk and outcomes in renal transplant patients treated with belatacept immunosuppression
JL Koff, GM Karadkhele, JM Switchenko, M Rupji, K Little, CP Larsen
Frontiers in Transplantation 2, 1280993, 2024
2024
2699. Risk of Bacterial Bloodstream Infection from a Urinary Source Among Kidney Transplant Recipients
E Eichenberger, G Karadkhele, AC Johnson, SM Pouch, CP Larsen
Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 2310, 2023
2023
Belatacept-Based Immunosuppression in Heart Transplant Recipients: National Trends with Outcomes from a Single Center
W Magua, AK Okoh, P Pranav, J Wang, G Karadkhele, R Cole, ...
The Journal of Heart and Lung Transplantation 42 (4), S248, 2023
2023
Validation of a dynamic prediction model of kidney allograft survival in pediatric kidney transplant recipients
G Karadkhele, F Manca, R Kabore, R Patzer, J Harambat, K Leffondre, ...
12th Congress of the International Pediatric Transplant Association 27 (S2 …, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20